Skip to main content

ST-Elevation Myocardial Infarction clinical trials at UCSF

1 research study open to eligible people

A st-elevation myocardial infarction is when a heart artery is blocked and part of the heart is damaged quickly. UCSF is running research for people who have more than one blocked heart artery. Some trials compare using blood flow measurements with imaging to pick which arteries to open first.

Showing trials for
  • Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

    open to eligible people ages 18 years and up

    COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients with acute ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease (CAD) who have undergone successful culprit lesion Percutaneous Coronary Intervention (PCI). COMPLETE-2 OCT is a large scale, prospective, multi-centre, observational, imaging study of patients with STEMI or NSTEMI and multivessel CAD in a subset of eligible COMPLETE-2 patients.

    San Francisco, California and other locations

Our lead scientists for ST-Elevation Myocardial Infarction research studies include .

Last updated: